24HourWire

24HourWire

News from all angles

MedPage Today Center

Abdakibart Shows Strong Early Efficacy in Hidradenitis Suppurativa

(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin…

Redirecting to MedPage Today in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network